- SGLT2 Inhibitors Attenuate Hypoxia and HIF1A Expression in Young Persons With Type 2 Diabetes
10:00 AM - 12:00 PM
SGLT2 Inhibitors Attenuate Hypoxia and HIF1A Expression in Young Persons With Type 2 Diabetes
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Nephron Segment Specific Response to SGLT2 Inhibitors in Young Persons With Type 2 Diabetes
10:00 AM - 12:00 PM
Nephron Segment Specific Response to SGLT2 Inhibitors in Young Persons With Type 2 Diabetes
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Empagliflozin Use and the Risk of Nephrolithiasis in Patients With Type 2 Diabetes
10:00 AM - 12:00 PM
Empagliflozin Use and the Risk of Nephrolithiasis in Patients With Type 2 Diabetes
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With CKD and Type 2 Diabetes
10:00 AM - 12:00 PM
Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With CKD and Type 2 Diabetes
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Canagliflozin on Markers of Hepatic Steatosis and Fibrosis in Patients With Type 2 Diabetes and CKD
10:00 AM - 12:00 PM
Effect of Canagliflozin on Markers of Hepatic Steatosis and Fibrosis in Patients With Type 2 Diabetes and CKD
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Canagliflozin (CANA) on Cardiovascular (CV), Kidney, and Albuminuria Outcomes by Diabetes Duration: Pooled Analysis From the CANVAS Program and CREDENCE
10:00 AM - 12:00 PM
Effects of Canagliflozin (CANA) on Cardiovascular (CV), Kidney, and Albuminuria Outcomes by Diabetes Duration: Pooled Analysis From the CANVAS Program and CREDENCE
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, Reduces the Risk of Cardiovascular and Renal Disease as Assessed by Steno Risk Engines in Adults With Type 1 Diabetes
10:00 AM - 12:00 PM
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, Reduces the Risk of Cardiovascular and Renal Disease as Assessed by Steno Risk Engines in Adults With Type 1 Diabetes
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Sotagliflozin (SOTA) on Albuminuria in Patients With Type 2 Diabetes (T2D) and CKD
10:00 AM - 12:00 PM
Effect of Sotagliflozin (SOTA) on Albuminuria in Patients With Type 2 Diabetes (T2D) and CKD
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Semaglutide Improves eGFR Slope vs. Placebo Regardless of Baseline HbA1c and Blood Pressure in People With Type 2 Diabetes: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
10:00 AM - 12:00 PM
Semaglutide Improves eGFR Slope vs. Placebo Regardless of Baseline HbA1c and Blood Pressure in People With Type 2 Diabetes: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Long-Term Use of Empagliflozin vs. DPP4 Inhibitors Mitigates eGFR Slopes in Patients With Type 2 Diabetes: Real-World Evidence
10:00 AM - 12:00 PM
Long-Term Use of Empagliflozin vs. DPP4 Inhibitors Mitigates eGFR Slopes in Patients With Type 2 Diabetes: Real-World Evidence
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Perceived Barriers to SGLT2i Prescription in Primary Care vs. Nephrology Providers: Findings From the Michigan Kidney Improvement Collaborative
10:00 AM - 12:00 PM
Perceived Barriers to SGLT2i Prescription in Primary Care vs. Nephrology Providers: Findings From the Michigan Kidney Improvement Collaborative
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6
10:00 AM - 12:00 PM
Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Tirzepatide vs. Insulin Glargine on Kidney Function Evaluated by Cystatin C-Based eGFR: A Post Hoc Analysis From the SURPASS-4 Trial
10:00 AM - 12:00 PM
Effects of Tirzepatide vs. Insulin Glargine on Kidney Function Evaluated by Cystatin C-Based eGFR: A Post Hoc Analysis From the SURPASS-4 Trial
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Improvement of Albuminuria by the Endothelin Receptor Antagonist Atrasentan Correlates to PCSK9 Reduction in Type 2 Diabetic Nephropathy Patients
10:00 AM - 12:00 PM
Improvement of Albuminuria by the Endothelin Receptor Antagonist Atrasentan Correlates to PCSK9 Reduction in Type 2 Diabetic Nephropathy Patients
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Safety and Efficacy of Maximally Tolerated RAS Therapy Alone or in Combination With Spironolactone in Diabetic Kidney Disease: Effect on Proteinuria and eGFR in the MRA-ACE Trial
10:00 AM - 12:00 PM
Safety and Efficacy of Maximally Tolerated RAS Therapy Alone or in Combination With Spironolactone in Diabetic Kidney Disease: Effect on Proteinuria and eGFR in the MRA-ACE Trial
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Spironolactone Wash-Out on Albuminuria After Long-Term Treatment: The AFTER-PRIORITY Study
10:00 AM - 12:00 PM
Effect of Spironolactone Wash-Out on Albuminuria After Long-Term Treatment: The AFTER-PRIORITY Study
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Finerenone on CKD Outcomes in Type 2 Diabetes: A Chinese Subgroup Analysis of the FIDELIO-DKD Study
10:00 AM - 12:00 PM
Effect of Finerenone on CKD Outcomes in Type 2 Diabetes: A Chinese Subgroup Analysis of the FIDELIO-DKD Study
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Cardiorenal Outcomes With Finerenone in Asian Patients With CKD and Type 2 Diabetes: Post Hoc Analysis From FIDELIO-DKD
10:00 AM - 12:00 PM
Cardiorenal Outcomes With Finerenone in Asian Patients With CKD and Type 2 Diabetes: Post Hoc Analysis From FIDELIO-DKD
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- The Effect of Magnesium Supplementation on Albuminuria in Patient With Type 2 Diabetic Mellitus in Phramongkutklao Hospital: A Randomized Double-Blinded Controlled Trial
10:00 AM - 12:00 PM
The Effect of Magnesium Supplementation on Albuminuria in Patient With Type 2 Diabetic Mellitus in Phramongkutklao Hospital: A Randomized Double-Blinded Controlled Trial
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Vacuolar Tubular Necrosis Caused by Hyperglycemia in a Diabetic Patient
10:00 AM - 12:00 PM
Vacuolar Tubular Necrosis Caused by Hyperglycemia in a Diabetic Patient
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Improving Daily Physical Activity in Patients Undergoing Hemodialysis Using Plantar Electrical Nerve Stimulation: A Randomized Double-Blinded Controlled Trial
10:00 AM - 12:00 PM
Improving Daily Physical Activity in Patients Undergoing Hemodialysis Using Plantar Electrical Nerve Stimulation: A Randomized Double-Blinded Controlled Trial
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Fasting Blood Glucose and the Risk of Cause-Specific Death in Hemodialysis Patients With Diabetes
10:00 AM - 12:00 PM
Fasting Blood Glucose and the Risk of Cause-Specific Death in Hemodialysis Patients With Diabetes
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Cost-Effectiveness Analysis of a Prognostic Risk Assessment Test for Diabetic Kidney Disease G1-G3b in the United States
10:00 AM - 12:00 PM
Cost-Effectiveness Analysis of a Prognostic Risk Assessment Test for Diabetic Kidney Disease G1-G3b in the United States
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Percutaneous Renal Biopsy Is Associated With Higher Bleeding Risks in Diabetics: A National Population Based Study
10:00 AM - 12:00 PM
Percutaneous Renal Biopsy Is Associated With Higher Bleeding Risks in Diabetics: A National Population Based Study
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Development in eGFR Trajectories in People With Diabetic Nephropathy
10:00 AM - 12:00 PM
Development in eGFR Trajectories in People With Diabetic Nephropathy
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Global Validation of a Minimal-Resource Pre-Screening Model for Reduced Kidney Function in Patients With Type 2 Diabetes
10:00 AM - 12:00 PM
A Global Validation of a Minimal-Resource Pre-Screening Model for Reduced Kidney Function in Patients With Type 2 Diabetes
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Transition Probabilities of Diabetic Kidney Disease (DKD) and Death in a Multi-Ethnic Asian Population
10:00 AM - 12:00 PM
Transition Probabilities of Diabetic Kidney Disease (DKD) and Death in a Multi-Ethnic Asian Population
November 05, 2022 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
